LONDON — The wellness category is wooing consumers and investors alike, and Iris Ventures is the newest fund to place its money behind products aimed toward enhancing the mind and body.
Iris, a growth equity fund targeting European and U.S. purpose-led, consumer-centric brands and tech-enabled solutions, has invested 5.5 million kilos in Biomel, a market-leading, plant-based gut health brand.
Biomel, founded in 2017 by husband-and-wife team Steven Hegarty and Janett Lozano, produces a spread of drinks, snack bars and powders at its innovation and manufacturing facility in west London.
Iris described the investment as strategic, and said it'll position Biomel for an “unprecedented scale-up,” and help the corporate pursue its mission of constructing “good gut health delicious.”
The investor argued that Biomel created the...
Continue reading
0 Comments
